Pink ribbons are recognized around the world as a symbol of breast cancer awareness, while endometriosis—a condition that can also profoundly affect daily life, relationships, education, and work—still struggles for comparable public recognition and action. Breast cancer has become one of the most recognizable public health causes, but this visibility was far from immediate; it took decades of advocacy, education, and people willing to challenge the stigma surrounding a disease that was once rarely discussed openly.
For those living with endometriosis, this history offers both hope and an important question: What would it take for a similarly misunderstood and often dismissed condition to receive the attention it deserves? Although endometriosis advocacy has made significant strides in recent years, many patients continue to experience delayed diagnosis, inadequate treatment, and dismissal of debilitating pain. Looking at how breast cancer awareness evolved can help guide endometriosis advocacy beyond raising awareness toward lasting changes in research, healthcare, and the experiences of those living with the disease.
For anyone who has only known the pink ribbon era, it may be surprising that breast cancer was once surrounded by fear, stigma, and secrecy. Discussing the disease openly was difficult, and its effects on the body, femininity, and sexuality could make diagnosis and treatment particularly isolating. The shift toward public recognition required people to challenge these cultural barriers and make breast cancer a legitimate subject of public discussion.
According to research published by Susan Braun in The Breast Journal, breast cancer advocacy developed through several stages, including public education and engagement, political advocacy, and broader institutional partnerships. Public figures who shared their experiences, such as former First Lady Betty Ford, helped make the disease more visible, while advocacy groups organized fundraising events and pushed for improvements in research and screening. In 1985, the American Cancer Society and Imperial Chemical Industries launched the first National Breast Cancer Awareness Month as a weeklong campaign. In 1992, the pink ribbon became the campaign’s symbol and went on to be recognized worldwide.
This progress did not happen simply because people learned that breast cancer existed. Advocacy connected public awareness to organized fundraising, research priorities, political action, and healthcare initiatives. Although breast cancer awareness campaigns have faced criticism for commercialization and for emphasizing symbolic participation over meaningful change, their history demonstrates how sustained collective action can transform public conversations about a disease.
Dr. Marisa Weiss, founder and chief medical officer of Breastcancer.org, emphasizes that organized patient advocacy has been central to this shift. “Leaps in breast cancer awareness have come from highly organized groups of patients who share their stories and unite to capture and command the attention of the general public, the medical and research communities, and legislators,” she explains. The goal, she notes, is to “advance research, improve access, and make sure care is patient-centric.” In her view, awareness becomes transformative when personal stories are connected to collective action.
Endometriosis faces many of the same barriers breast cancer once did. The disease often interferes with education, employment, relationships, mental health, and everyday activities. Despite its prevalence and impact, endometriosis remains widely misunderstood. Menstrual pain is frequently normalized, and patients often struggle to have their symptoms taken seriously by family, friends, coworkers, and healthcare professionals. A review by Sims et al. (2021) describes how stigma surrounding menstruation and chronic pain can contribute to diagnostic delays and negatively affect psychological well-being. The World Health Organization (2025) likewise identifies stigma and misconceptions about menstrual pain as barriers to timely diagnosis and quality care.
Endometriosis advocacy, however, is not new. Patients and advocates have spent decades sharing information, building communities, and challenging misconceptions. Social media has created additional opportunities for people to discuss their experiences and find others who understand their struggles. Still, greater visibility has not eliminated the systemic barriers patients face. What the comparison with breast cancer reveals is not a lack of advocates; it is the distance between an active advocacy community and widespread public recognition that translates into systemic action.
Breast cancer advocacy offers several lessons for strengthening the endometriosis movement. First, consistent public messaging can help make a complex condition recognizable. The pink ribbon became a symbol through which individuals, organizations, and institutions could communicate solidarity. Endometriosis advocates can build on existing awareness campaigns and symbols while making clear that severe menstrual pain is not something people should be expected to endure. For that message to be effective, though, symbols must be accompanied by accessible, accurate information about symptoms, diagnosis, and treatment.
Second, patient stories must remain central. Personal narratives can make an unfamiliar condition understandable by showing how it affects real lives. Endometriosis advocates can use podcasts, social media, community events, and partnerships with traditional media to amplify patient experiences. These stories should reflect the full range of people living with endometriosis, including adolescents, people of color, LGBTQ+ people, and those whose symptoms or circumstances do not fit common stereotypes. Greater representation can challenge assumptions about who develops endometriosis and whose pain deserves attention.
Weiss points to the impact of public figures who speak openly about their experiences. Reflecting on Angelina Jolie’s decision to share that she carried a BRCA gene variant, Weiss says the disclosure encouraged many more women to pursue genetic testing. She also names Lena Dunham, Padma Lakshmi, and Amy Schumer, all of whom have spoken publicly about endometriosis, as people whose visibility can help bring a condition into public conversation. For endometriosis advocates, the lesson is not that celebrity stories should replace everyday patient voices, but that trusted, visible messengers can help those voices reach broader audiences.
Third, advocacy needs partnerships beyond patient communities. Collaboration among researchers, healthcare providers, schools, employers, nonprofits, and policymakers can extend awareness into everyday institutions. Healthcare education should emphasize symptom recognition, respectful communication, and appropriate referral pathways. Schools can provide accurate menstrual health education, and employers can develop supportive practices for employees living with endometriosis.
Finally, awareness must connect to measurable improvements. As Weiss puts it, “Attention is only the starting point.” She argues that lasting campaigns pair visibility with a clear next step, such as finding trusted information, joining a community, or pursuing appropriate screening, while also investing in research, policy change, and patient support. For endometriosis, that means judging progress by outcomes such as earlier diagnosis, better access to knowledgeable care, and patients who are better informed, rather than by campaign reach alone.
The history of breast cancer awareness shows that public recognition is built through sustained advocacy, collaboration, and demands for meaningful change. Endometriosis advocates have already laid important groundwork, but continued progress requires more than dedicating a month to the cause or sharing a ribbon online. Awareness should lead to action: clinicians who listen, researchers who receive the resources to investigate unanswered questions, institutions that recognize the effects of chronic illness, and patients who no longer have to fight to have their symptoms believed. The endometriosis movement does not need to replicate breast cancer advocacy in every respect. It can, however, learn from how patient voices, public education, and organized action helped reshape a once-stigmatized and misunderstood disease.
Weiss advises emerging movements to “put people with lived experience at the center” and to establish “a reliable, medically vetted source of information early, because trust is what lasts.” She also cautions against letting a message become diluted or commercialized without producing real benefits for patients. Her advice is practical: “Start with one step, get good at it, feel proud of it, share it, and inspire others.” That approach offers endometriosis advocates a way to turn individual acts of visibility into sustained, collective progress.
